Open original FDA record ↗Recall record
- FDA identifier
- Z-1547-2020
- Company in FDA record
- Randox Laboratories Ltd.
- FDA record creation date
- Mar 20, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The control target and range value for Sodium using the ISE indirect method has been assigned incorrectly.
Source facts
- Action
- On February 18, 2020, the firm notified customers of the action via emailed Urgent Medical Device Correction letters. Customers were informed of the incorrectly assigned control target and range value for Sodium using the ISE indirect method. The letter stated that the sections for Roche Cobas series and mean of all instruments has now been updated, and the updated value sheets were included with the email. The updated value sheets may also be found on www.randox.com. Customers were asked to take the following actions: - Review results generated with the affected batches in line with the clinical profile of the patient. -Discuss the contents of the notice with your Medical Director. -Complete and return the included response form within 5 working days. Distributors were asked to forward a copy of the notice to all affected customers. If you have questions or concerns, please contact Randox Technical Services: 866-4-RANDOX, or customersupportusa@randox.com
- Initiated
- 2020-02-18
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide distribution - US Nationwide distribution in the states of WV, IN, VA, ID, PR, DE, and countries of West Indies, Czech Republic, France, Germany, Hong Kong, Ireland, Italy, Norway, Philippines, South Africa, South Korea, Sweden, Taiwan (R.O.C.), Thailand, UAE, UK.
- Recall number
- Z-1547-2020
- Recall status
- Open, Classified
- CDRH record ID
- 179939
- FDA record created
- 2020-03-20
- Recall event number
- 85030